Intravenous Immunoglobulin Market Size, Share & Industry Analysis By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Regional Forecast, 2025-2032

Last Updated: April 09, 2025 | Format: PDF | Report ID: FBI100593

To get information on various segments, share your queries with us

SEGMENTATION	DETAILS
By Indication	Primary Immunodeficiency Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Guillain-Barré Syndrome (GBS) Immune Thrombocytopenic Purpura (ITP) Multifocal Motor Neuropathy (MMN) Others
By Form	Liquid Lyophilized
By End User	Hospitals Clinics Homecare
By Geography	North America (the U.S., and Canada) Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe) Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)